Market Overview

Morgan Stanley: Veeva Systems' Share Price Fails To Reflect Growth, Margin Potential

Share:
Morgan Stanley: Veeva Systems' Share Price Fails To Reflect Growth, Margin Potential
Related VEEV
21 Stocks Moving In Thursday's Pre-Market Session
Benzinga's Top Upgrades, Downgrades For December 4, 2018

Veeva Systems Inc (NYSE: VEEV), a cloud-computing company focused on the pharma and life sciences industry, is an underpriced asset within the broader SaaS universe, according to Morgan Stanley. 

The Analyst

Morgan Stanley analyst Stan Zlotsky upgraded Veeva Systems from Equal-weight to Overweight and increased the price target from $69 to $72.

The Thesis

Veeva Systems has durable growth — fueled by an expanding $17-billion total addressable market — and margin potential that is not being reflected in current trading levels, Zlotsky said in a Tuesday note. A conservative setup into 2019 offers scope for estimates and shares to move up, he said. 

The company's best-in-class economics are likely to drive longer-term operating margin to 43 percent, representing the highest margin potential in Morgan Stanley's coverage universe, Zlotsky said.

"Veeva's above average sales efficiency and a disciplined go-to-market has enabled the company to simultaneously deliver strong revenue growth and greater than 30-percent operating margins today, well above the 18-percent average among more mature SaaS peers," the analyst said. 

Morgan Stanley estimates 16-percent revenue growth on a CAGR basis to $1.7 billion and a 36-percent operating margin by calendar year 2023, resulting in free cash flow of $593 million. 

With the 12-percent pullback in Veeva Systems shares since June 2017 compared to a 14-percent gain for the SaaS peer group, Morgan Stanley sees an attractive entry point to rebuild positions in the shares.

The Price Action

Veeva Systems shares are up over 41 percent year-to-date.

Shares were up 0.60 percent at $60.68 after the open Tuesday.

Related Links:

Mizuho: After Industry Consolidation, Cloudera Emerges As A Buy

6 Reasons To Hold On To Salesforce Stock

Latest Ratings for VEEV

DateFirmActionFromTo
Dec 2018Leerink SwannInitiates Coverage OnOutperform
Nov 2018Morgan StanleyMaintainsOverweightOverweight
Nov 2018KeyBancMaintainsOverweightOverweight

View More Analyst Ratings for VEEV
View the Latest Analyst Ratings

Posted-In: cloud computing life sciences Morgan Stanley pharmaAnalyst Color Upgrades Price Target Analyst Ratings Best of Benzinga

 

Related Articles (VEEV)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
SYBXChardan CapitalInitiates Coverage On20.0
GEJP MorganUpgrades6.0
FEYEMorgan StanleyDowngrades21.0
ADCJefferiesUpgrades70.0
HTAJefferiesDowngrades0.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

5 Biggest Price Target Changes For Tuesday

Benzinga's Top Upgrades, Downgrades For January 30, 2018